Point-of-Care Diabetes Management Chemistry Analyzer — Bayer DCA 2000+

The Bayer DCA 2000+ is a trusted point-of-care chemistry analyzer, commonly found in physician offices, diabetes clinics, and specialty practices. It is engineered to provide rapid, actionable results for monitoring long-term glycemic control and detecting early kidney disease in diabetic patients.

This benchtop system streamlines the testing process, allowing healthcare professionals to have critical diagnostic information available during the patient visit. This immediate feedback facilitates timely adjustments to treatment plans and enhances patient education and engagement.

• Primary Assays: Measures Hemoglobin A1c (HbA1c) from a small whole blood sample.
• Kidney Health: Analyzes Albumin, Creatinine, and the Albumin-to-Creatinine (A:C) ratio from a urine sample.
• Efficiency: Delivers quantitative results in minutes, eliminating the delays associated with sending samples to an external laboratory.
• User-Friendly: Designed for straightforward operation in a clinical setting, requiring minimal training.

For clinics focused on proactive diabetes management, the DCA 2000+ analyzer is a valuable asset for improving patient outcomes and optimizing workflow.